<DOC>
	<DOCNO>NCT00003110</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . PURPOSE : Phase II trial study effectiveness bleomycin treat patient non-Hodgkin 's lymphoma .</brief_summary>
	<brief_title>Bleomycin Treating Patients With Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine objective response rate , response duration survival patient receive bleomycin salvage therapy AIDS-related immunocompetent non-Hodgkin 's lymphoma . II . Assess feasibility toxicity treatment disease . III . Evaluate quality life AIDS non-AIDS patient non-Hodgkin 's lymphoma . OUTLINE : Patients stratify number prior cytotoxic chemotherapy regimen , prior radiotherapy , HIV/AIDS status . Patients receive bleomycin continuous infusion 72 hour every 3 week . Induction therapy consist 3 cycle . Patients achieve complete remission receive 2 cycle . Patients partial remission stable disease may continue therapy disease progression unacceptable toxicity occur . Quality life assessment conduct begin therapy , every 3 week , completion treatment . Patients follow every 3 month overall survival . PROJECTED ACCRUAL : A total 32 patient accrue .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm recurrent intermediate high grade nonHodgkin 's lymphoma ( NHL ) AIDSrelated NHL eligible At least 1 evaluable measurable disease define follow : Radiographic finding acceptable Bidimensionally measurable defect compute tomographic ( CT ) scan Clearly define abdominal mass CT scan Enlarged spleen and/or liver extend least 5 cm costal margin Biopsy proven lymphomatous hepatic involvement No clinical radiographic evidence parenchymal CNS involvement lymphoma ( meningeal lymphoma permit ) A new classification scheme adult nonHodgkin 's lymphoma adopt PDQ . The terminology `` indolent '' `` aggressive '' lymphoma replace former terminology `` low '' , `` intermediate '' , `` high '' grade lymphoma . However , protocol us former terminology . PATIENT CHARACTERISTICS : Age : Any age Performance status : ECOG 03 Life expectancy : At least 6 week Hematopoietic : WBC least 1500/mm3 Platelet count least 50,000/mm3 Hepatic : Bilirubin great 3.0 mg/dL Renal : Creatinine great 3.0 mg/dL Other : May HIV positive Immunocompetent ( HIVseronegative ) NHL patient must suitable candidate bleomycin chemotherapy Active infection undergo drug treatment allow Negative head CT/MRI scan PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 1 prior systemic chemotherapy regimen Endocrine therapy : Not specify Radiotherapy : Prior radiation therapy localize stage I/II disease progress beyond initial radiation therapy port allow Surgery : Not specify Other : Concurrent zidovudine , didanosine , zalcitabine therapy allow</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>recurrent childhood lymphoblastic lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult lymphoblastic lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>AIDS-related peripheral/systemic lymphoma</keyword>
	<keyword>AIDS-related diffuse large cell lymphoma</keyword>
	<keyword>AIDS-related immunoblastic large cell lymphoma</keyword>
	<keyword>AIDS-related small noncleaved cell lymphoma</keyword>
	<keyword>AIDS-related diffuse mixed cell lymphoma</keyword>
	<keyword>AIDS-related diffuse small cleave cell lymphoma</keyword>
	<keyword>AIDS-related lymphoblastic lymphoma</keyword>
	<keyword>recurrent childhood small noncleaved cell lymphoma</keyword>
	<keyword>recurrent childhood large cell lymphoma</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
</DOC>